What should be monitored in patients receiving antiviral therapy? -
ANSWER Monitor for signs of superinfection and ensure adherence to the
medication schedule.
How should fluids be managed in patients receiving antivirals? -
ANSWER Increase fluid intake to 3 L/day to decrease crystalluria when given
IV.
What should be done if a patient experiences severe abdominal pain while on
medication? - ANSWER Discontinue the agent and assess for potential
complications.
What is the significance of monitoring hepatic function in patients on certain
medications? - ANSWER To detect potential hepatotoxicity early and adjust
treatment as necessary.
, What is the primary action of bisphosphonates? - ANSWER They absorb
calcium phosphate crystals in bone and inhibit normal and abnormal bone
resorption and mineralization.
How do selective estrogen receptor modulators function? - ANSWER They
reduce bone resorption and decrease bone turnover through estrogen receptor
binding.
What are the main uses of bone resorption inhibitors? - ANSWER They are
used for the prevention and treatment of osteoporosis in postmenopausal women,
the treatment of Paget's disease, and the treatment of osteoporosis in men.
What should be monitored before starting treatment with bone resorption
inhibitors? - ANSWER Renal and hepatic function tests, including protein,
BUN, and creatinine levels.
What precautions should be taken when using bone resorption inhibitors? -
ANSWER Use cautiously in pregnancy, breastfeeding, geriatric patients,
renal/hepatic disease, and some GI disorders.
What should patients be advised regarding the dosage of bone resorption
inhibitors? - ANSWER Patients should comply with the dosage schedule, even
if feeling better.
What are the uses of calcium channel blockers? - ANSWER They are used for
chronic stable angina pectoris, vasospastic angina, dysrhythmias, hypertension, and
unstable angina.
,What are common side effects of calcium channel blockers? -
ANSWER Dizziness, hypotension, and bradycardia.
What should be monitored when administering cardiac glycosides? -
ANSWER Cardiac system parameters such as blood pressure, pulse,
respirations, and ECG intervals.
What is the primary action of cardiac glycosides? - ANSWER They inhibit
sodium and potassium ATPase, increasing calcium availability to activate
contracted proteins, thus enhancing cardiac contractility and output.
What are the contraindications for using cardiac glycosides? - ANSWER They
should not be used in patients with 2nd- or 3rd-degree heart block, sick sinus
syndrome, hypotension, or cardiogenic shock.
What are common adverse effects of cholinergics? - ANSWER Cardiac
disturbances, headache, hypotension, GI symptoms, blurred vision, and yellow-
green halos.
What is the action of cholinergics? - ANSWER They prevent the destruction of
acetylcholine, increasing its concentration at release sites, which facilitates impulse
transmission across the myoneural junction.
What should be monitored in patients taking cholinergics? - ANSWER Cardiac
system parameters, electrolytes, renal function tests, and therapeutic product levels.
, What is a key nursing consideration for administering cardiac glycosides? -
ANSWER Monitor apical pulse for 1 minute before administration; if pulse is
less than 60, notify the prescriber.
What is the pharmacokinetics of bisphosphonates? - ANSWER Onset, peak,
and duration vary widely among products; most are taken up by bones and
excreted by the kidneys.
What should patients be educated about regarding cardiac glycosides? -
ANSWER They should remain upright for at least 30 minutes after taking to
prevent esophageal irritation.
What are the generic names of bisphosphonates? - ANSWER Alendronate,
etidronate, ibandronate, pamidronate, risedronate.
What is the role of patient education in the use of calcium channel blockers? -
ANSWER Patients should be taught to take their pulse before taking the product
and to avoid hazardous activities until stabilized.
What are the indications for using selective estrogen receptor modulators? -
ANSWER They are indicated for the treatment and prevention of osteoporosis.
What should be done if a patient experiences significant changes in pulse while
taking bone resorption inhibitors? - ANSWER Notify the prescriber of
significant changes.
ANSWER Monitor for signs of superinfection and ensure adherence to the
medication schedule.
How should fluids be managed in patients receiving antivirals? -
ANSWER Increase fluid intake to 3 L/day to decrease crystalluria when given
IV.
What should be done if a patient experiences severe abdominal pain while on
medication? - ANSWER Discontinue the agent and assess for potential
complications.
What is the significance of monitoring hepatic function in patients on certain
medications? - ANSWER To detect potential hepatotoxicity early and adjust
treatment as necessary.
, What is the primary action of bisphosphonates? - ANSWER They absorb
calcium phosphate crystals in bone and inhibit normal and abnormal bone
resorption and mineralization.
How do selective estrogen receptor modulators function? - ANSWER They
reduce bone resorption and decrease bone turnover through estrogen receptor
binding.
What are the main uses of bone resorption inhibitors? - ANSWER They are
used for the prevention and treatment of osteoporosis in postmenopausal women,
the treatment of Paget's disease, and the treatment of osteoporosis in men.
What should be monitored before starting treatment with bone resorption
inhibitors? - ANSWER Renal and hepatic function tests, including protein,
BUN, and creatinine levels.
What precautions should be taken when using bone resorption inhibitors? -
ANSWER Use cautiously in pregnancy, breastfeeding, geriatric patients,
renal/hepatic disease, and some GI disorders.
What should patients be advised regarding the dosage of bone resorption
inhibitors? - ANSWER Patients should comply with the dosage schedule, even
if feeling better.
What are the uses of calcium channel blockers? - ANSWER They are used for
chronic stable angina pectoris, vasospastic angina, dysrhythmias, hypertension, and
unstable angina.
,What are common side effects of calcium channel blockers? -
ANSWER Dizziness, hypotension, and bradycardia.
What should be monitored when administering cardiac glycosides? -
ANSWER Cardiac system parameters such as blood pressure, pulse,
respirations, and ECG intervals.
What is the primary action of cardiac glycosides? - ANSWER They inhibit
sodium and potassium ATPase, increasing calcium availability to activate
contracted proteins, thus enhancing cardiac contractility and output.
What are the contraindications for using cardiac glycosides? - ANSWER They
should not be used in patients with 2nd- or 3rd-degree heart block, sick sinus
syndrome, hypotension, or cardiogenic shock.
What are common adverse effects of cholinergics? - ANSWER Cardiac
disturbances, headache, hypotension, GI symptoms, blurred vision, and yellow-
green halos.
What is the action of cholinergics? - ANSWER They prevent the destruction of
acetylcholine, increasing its concentration at release sites, which facilitates impulse
transmission across the myoneural junction.
What should be monitored in patients taking cholinergics? - ANSWER Cardiac
system parameters, electrolytes, renal function tests, and therapeutic product levels.
, What is a key nursing consideration for administering cardiac glycosides? -
ANSWER Monitor apical pulse for 1 minute before administration; if pulse is
less than 60, notify the prescriber.
What is the pharmacokinetics of bisphosphonates? - ANSWER Onset, peak,
and duration vary widely among products; most are taken up by bones and
excreted by the kidneys.
What should patients be educated about regarding cardiac glycosides? -
ANSWER They should remain upright for at least 30 minutes after taking to
prevent esophageal irritation.
What are the generic names of bisphosphonates? - ANSWER Alendronate,
etidronate, ibandronate, pamidronate, risedronate.
What is the role of patient education in the use of calcium channel blockers? -
ANSWER Patients should be taught to take their pulse before taking the product
and to avoid hazardous activities until stabilized.
What are the indications for using selective estrogen receptor modulators? -
ANSWER They are indicated for the treatment and prevention of osteoporosis.
What should be done if a patient experiences significant changes in pulse while
taking bone resorption inhibitors? - ANSWER Notify the prescriber of
significant changes.
